Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphate

Cancer Res. 1991 Apr 1;51(7):1829-35.

Abstract

The effects of fludarabine triphosphate (Fara-ATP), 1-beta-D-arabinofuranosylcytosine 5'-triphosphate (ara-CTP), and aphidicolin on primer RNA and DNA synthesis in human CCRF-CEM leukemia cells were investigated. RNA-primed Okazaki fragment synthesis was monitored by first incubating whole cell lysates for 10 min in the presence or absence of the compound and then following the incorporation of [alpha-32P]ATP and [3H]dTTP into the primer RNA and DNA portions, respectively, of the Okazaki fragments. In whole cell lysates the degree of DNA synthesis inhibition induced by Fara-ATP was directly related to the extent of primer RNA synthesis inhibition over the entire range of Fara-ATP concentrations tested (10-50 microM). In contrast, primer RNA formation was stimulated by concentrations of ara-CTP (25-200 microM) and aphidicolin (0.5-5 micrograms/ml) that inhibited DNA synthesis. The primer RNA recovered from cell lysates incubated with either Fara-ATP, ara-CTP, or aphidicolin was of normal length, predominately 11 nucleotides. Fara-ATP was a more potent inhibitor of the polydeoxythymidylate primase activity than of the DNA polymerase alpha/delta activities present in the 100,000 x g supernatants of CCRF-CEM cells. Fara-ATP was a noncompetitive inhibitor of DNA primase with respect to ATP [50% inhibitory concentration, 2.3 +/- 0.3 (SD) microM, Ki = 6.1 +/- 0.3 (SE) microM] and the Km(ATP)/Ki (Fara-ATP) was 25. The 50% inhibitory concentration values of Fara-ATP for DNA polymerases alpha/delta activities on calf thymus DNA were 43 +/- 1.6 (SD) microM and greater than 100 microM with respect to dATP and dTTP. The effects of ara-CTP and aphidicolin on these enzymes were opposite those seen with Fara-ATP, since 50% inhibitory concentrations of either ara-CTP or aphidicolin for DNA polymerases alpha/delta did not inhibit polydeoxythymidylate primase activity. The results provide evidence that fludarabine phosphate blocks DNA synthesis in CCRF-CEM cells through inhibition of primer RNA formation. In contrast, the accumulation of primer RNA and RNA-primed Okazaki fragments that is induced by ara-CTP and aphidicolin could lead to the rereplication and amplification of chromosomal DNA segments.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aphidicolin
  • Arabinofuranosylcytosine Triphosphate / pharmacology
  • DNA Primase
  • DNA, Neoplasm / biosynthesis*
  • DNA-Directed DNA Polymerase / biosynthesis*
  • Deoxyguanine Nucleotides / pharmacology
  • Diterpenes / pharmacology
  • Humans
  • Leukemia / metabolism*
  • RNA / biosynthesis*
  • RNA Nucleotidyltransferases / biosynthesis*
  • Tumor Cells, Cultured
  • Vidarabine Phosphate / analogs & derivatives*
  • Vidarabine Phosphate / pharmacology

Substances

  • DNA, Neoplasm
  • Deoxyguanine Nucleotides
  • Diterpenes
  • RNA primers
  • Vidarabine Phosphate
  • Arabinofuranosylcytosine Triphosphate
  • fludarabine phosphate
  • ara-ATP
  • Aphidicolin
  • RNA
  • N(2)-(4-n-butylphenyl)-2'-deoxyguanosine 5'-triphosphate
  • DNA Primase
  • RNA Nucleotidyltransferases
  • DNA-Directed DNA Polymerase